Product Details
Ceftazidime Injection powder for solution
250mg/500mg/1g/2g
Product Description :
CEFTAZIDIME INJECTION 250 mg / 500 mg / 1 g / 2 g
Sterile Powder for Solution for Intravenous or Intramuscular Administration
1. COMPOSITION
Each vial contains:
• Ceftazidime Pentahydrate equivalent to Ceftazidime 250 mg / 500 mg / 1 g / 2 g.
• Excipients: As applicable.
2. PHARMACEUTICAL FORM
Sterile, white to off-white powder for solution for intravenous or intramuscular administration.
3. THERAPEUTIC CLASS
Third-Generation Cephalosporin Antibiotic.
4. INDICATIONS
Ceftazidime Injection is indicated for the treatment of susceptible bacterial infections, including:
• Lower respiratory tract infections.
• Urinary tract infections.
• Intra-abdominal infections.
• Skin and soft-tissue infections.
• Bone and joint infections.
• Biliary tract infections.
• Septicemia and other serious bacterial infections.
• Infections caused by susceptible Pseudomonas aeruginosa.
Treatment should be guided by the susceptibility of the causative organism and applicable antimicrobial guidelines.
5. CONTRAINDICATIONS
• Hypersensitivity to ceftazidime, cephalosporins, or any component of the formulation.
• History of severe immediate hypersensitivity reactions to beta-lactam antibiotics.
6. DRUG INTERACTIONS
• Concomitant nephrotoxic medicines may increase the risk of renal toxicity.
• Diuretics such as furosemide may require caution when used with ceftazidime.
• Anticoagulants may require appropriate monitoring.
• Other medicines affecting renal function should be used with caution.
The treating physician should review all concomitant medications before administration.
7. ADMINISTRATION
For intravenous or intramuscular administration after reconstitution with a compatible diluent under aseptic conditions. Administer according to the approved product information and institutional protocol.
8. STORAGE
Store according to the storage conditions stated on the approved product label. Protect from excessive heat, moisture and light. After reconstitution, use within the period specified in the approved product information. Do not use if the reconstituted solution shows visible particles, precipitation or unexpected discoloration.